CAVC Case 24-293: Back
CAVCReal U.S. Court of Appeals for Veterans Claims (CAVC) decision · 2025-05-30 · PIETSCH, Judge
This is a decision of the U.S. Court of Appeals for Veterans Claims — the federal court that reviews Board of Veterans' Appeals decisions, one level above the Board. Court decisions can vacate, reverse, or affirm what the Board did.
Official 2026 VA monthly compensation, including the 2.8% COLA increase.
Dependent add-ons start at a 30% rating. Child-only and dependent-parent rates: see the full 2026 pay chart.
2026 base rates, all ratings (veteran alone)
| Rating | Monthly (2026, incl. 2.8% COLA) |
|---|---|
| 10% | $180.42 |
| 20% | $356.66 |
| 30% | $552.47 |
| 40% | $795.84 |
| 50% | $1,132.90 |
| 60% | $1,435.02 |
| 70% | $1,808.45 |
| 80% | $2,102.15 |
| 90% | $2,362.30 |
| 100% | $3,938.58 |
Conditions Claimed
BackShoulderAnkleSkinHeartRespiratoryGI
Referral disclosure: VetAid earns a referral fee if you become a paying REE Medical client through this link — it helps keep this site free. REE Medical provides paid medical evidence; it is not a law firm, VSO, or claims agent, and VetAid has not independently verified its services. VSOs and VA-accredited representatives will help you file your claim at no cost, and no one can guarantee a rating increase.
Issues on Appeal
Back ConditionService ConnectionIncreased Rating
Why It Was Decided This Way
Specifically,the Board noted that the appellant reported to have received treatment for all his claim conditions at Munson Army Health Center in Ft.
The Board found that because there may be outstanding and relevant 2 Case:24-293 Page: 3 of 13 Filed:05/30/2025 treatment records from a U.
Army health care center,a remand is required to allow VA to request these records.
The Board denied entitlement to initial compensable ratings for the appellant's hemorrhoids and scars of the trunk and extremities.
In addition,the Board denied a separate initial compensable rating for mast cell activation syndrome under Diagnostic Code 6522.
On remand,the Board was directed to ensure that all of the appellant's outstanding treatment records from Munson Army Health Center are obtained in compliance with the duty to assist and the January 2020 Board remand instructions.
In the September 28,2023,decision,the Board denied an initial evaluation in excess of 60%for mast cell activation syndrome with facial flushing and a skin rash and further denied a separate compensable evaluation for mast cell activation under DC 6522.
In addition, the Board denied initial compensable ratings for the appellant's scars and hemorrhoids and also denied an initial rating in excess of 10% for GERD with hiatal hernia.
Authorities Cited
Denial Type
Non Denial Outcome
Find Similar Decisions for Your Claim
VetAid's analyzer maps your claim against thousands of real Board of Veterans' Appeals decisions like this one — surfacing the exact case law that supports your arguments.
Run my claim through VetAid →